Benitec Biopharma Inc. (BNTC)
11.75
-0.67 (-5.39%)
At close: Mar 04, 2025, 9:38 AM
Benitec Biopharma Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 50.87M | 2.48M | 4.06M | 19.77M | 9.8M | 15.7M | 11.82M | 13.35M | 13.61M | 16.71M | 20.51M | 28.62M |
| Short-Term Investments | n/a | n/a | n/a | n/a | 1K | 126.76K | 22.04K | 76.84K | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 87K | 122K | 160K | 194K | -148K | 9.1K | 91.82K | 45.34K | n/a | n/a | n/a | n/a |
| Receivables | 229K | n/a | 3K | 25K | 59K | 2.54M | 134K | 3.39M | n/a | n/a | 115.8K | 111.34K |
| Inventory | n/a | 13K | 1.80 | n/a | 948K | 1.00 | -0.00 | -65.07K | 111.27K | 2.13M | 2.61M | 2.49M |
| Other Current Assets | 579K | 1.25M | 755K | 814K | 949K | 502K | 771.32K | 562K | 132.18K | 271.12K | 384.77K | 2.52M |
| Total Current Assets | 51.67M | 3.73M | 4.82M | 20.61M | 10.81M | 18.73M | 15.35M | 17.03M | 14.48M | 19.22M | 23.6M | 31.44M |
| Property-Plant & Equipment | 449K | 613K | 993K | 577K | 769K | 469.23K | 234.33K | 341.96K | 377.87K | 349.75K | 429.32K | 43.8K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 536K | 735K | 1.15M | 771K | 778K | 478.33K | 326.16K | 387.3K | 377.87K | 349.75K | 429.32K | 43.8K |
| Total Assets | 52.21M | 4.46M | 5.97M | 21.38M | 11.59M | 19.21M | 15.68M | 17.42M | 14.85M | 19.57M | 24.03M | 31.48M |
| Account Payables | 1.35M | 1.14M | 422K | 274K | 282K | 1.47M | 426.06K | 133.71K | 401.77K | 582.92K | 715.54K | 522.92K |
| Deferred Revenue | n/a | -1.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 284K | 275K | 252K | 213K | 192K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 3.29M | 2.56M | 1.86M | 882K | 662K | 1.16M | 2.12M | 730.8K | 633.23K | 676.49K | 830.4K | 348.61K |
| Total Current Liabilities | 4.92M | 3.98M | 2.53M | 1.37M | 1.14M | 2.64M | 1.87M | 864.51K | 772.92K | 1.26M | 1.55M | 871.53K |
| Long-Term Debt | n/a | 284K | 559K | n/a | 213K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 38K | n/a | n/a | n/a | n/a | n/a | 35.26K | 26.89K | 13.44K | n/a | n/a | n/a |
| Total Long-Term Liabilities | 38K | 284K | 559K | n/a | 213K | n/a | 35.26K | 26.89K | 13.44K | n/a | n/a | n/a |
| Total Liabilities | 4.96M | 4.26M | 3.09M | 1.37M | 1.35M | 2.64M | 1.91M | 891.4K | 786.36K | 1.26M | 1.55M | 871.53K |
| Total Debt | 284K | 559K | 811K | 213K | 405K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock | 1K | n/a | 1K | 1K | 1K | 114.92M | 120.54M | 119.56M | 110.26M | 99.43M | 122.05M | 117.9M |
| Retained Earnings | -190.26M | -167.89M | -148.33M | -130.12M | -116.64M | -98.93M | -107.86M | -104.32M | -98.1M | -82.68M | -101.48M | -87.87M |
| Comprehensive Income | -892K | -830K | -1.25M | -1.46M | -1.95M | 581.98K | 1.1M | 1.29M | 1.92M | 1.56M | 1.92M | 584.98K |
| Shareholders Equity | 47.25M | 202K | 2.88M | 20.01M | 10.24M | 16.57M | 13.77M | 16.53M | 14.07M | 18.31M | 22.48M | 30.61M |
| Total Investments | n/a | n/a | n/a | n/a | 1K | 126.76K | 22.04K | 76.84K | n/a | n/a | n/a | n/a |